Opuntiol Inhibits Growth and Induces Apoptosis in Human Glioblastoma Cells by Upregulating Active Caspase 3
Ambreen Ashfaque1, Farina Hanif2, Shabana Usman Simjee3
1Department of Physiology, Dow International Medical College, Dow University of Health Sciences, OJHA Campus, SUPARCO Road, Karachi, Pakistan.
Background:
Glioblastoma Multiforme (GBM) is a deadly tumor with poor prognosis. Resistance to apoptosis considered as an important factor in treatment failure. Therefore, identification of new compounds that facilitates apoptosis is crucial. Natural Anti-inflammatory compounds have emerged as potential anti-cancer agents and should be explored for their apoptotic activity against GBM. Therefore, the present study aims to evaluate growth inhibitory and apoptotic activity of a natural anti-inflammatory compound "Opuntiol" against GBM cell line U87.
Methods:
MTT assay was performed to determine the effect of Temozolomide and Opuntiol on growth inhibition of U87 cell. While, TUNEL assay was used to assess their apoptotic activity. To further assess apoptosis, nuclear condensation and nuclear area factor (NAF) was evaluated through DAPI staining. Whereas, active caspase-3 protein expression determined using immunocytochemistry.
Results:
Significant growth inhibition was observed in U87 cells treated with Temozolomide (IC50 380 µM) and Opuntiol (IC50 357 µM). Temozolomide (p<0.001) and Opuntiol (p<0.001) significantly improved rate of apoptosis when compared to control group. A significant decrease in NAF was also observed in Temozolomide (p < 0.05) and Opuntiol (p < 0.05) treated cells. There was a significant increase in active caspase-3 expression when observed in Temozolomide (p<0.001) and Opuntiol (p<0.05) treated groups as compared to control.
Conclusion:
In conclusion our findings suggests, Opuntiol repress cell viability and possess strong apoptotic activity against GBM cell line U-87. However, further mechanistic studies will be required to confirm whether it can be develop as a potential drug against GBM.
Insights
Opuntiol, a natural anti-inflammatory compound, effectively inhibits Glioblastoma Multiforme (GBM) cell growth and induces apoptosis. This natural compound shows promise as a potential therapeutic agent against this deadly brain cancer.
Area of Science:
- Oncology
- Natural Product Chemistry
- Molecular Biology
Background:
- Glioblastoma Multiforme (GBM) is an aggressive brain tumor with a poor prognosis.
- Therapeutic resistance, particularly apoptosis resistance, contributes to treatment failure in GBM.
- Natural anti-inflammatory compounds are being explored for their anti-cancer properties.
Purpose of the Study:
- To evaluate the growth inhibitory effects of Opuntiol on the U87 GBM cell line.
- To assess the apoptotic activity of Opuntiol in U87 GBM cells.
- To compare the efficacy of Opuntiol with Temozolomide, a standard GBM treatment.
Main Methods:
- MTT assay for cell viability and growth inhibition.
- TUNEL assay and DAPI staining for apoptosis assessment (nuclear condensation, NAF).
- Immunocytochemistry to determine active caspase-3 protein expression.
Main Results:
- Opuntiol demonstrated significant growth inhibition of U87 cells with an IC50 of 357 µM.
- Both Opuntiol and Temozolomide significantly increased apoptosis rates and active caspase-3 expression.
- A significant decrease in nuclear area factor (NAF) was observed in Opuntiol-treated cells.
Conclusions:
- Opuntiol exhibits significant cell viability repression and potent apoptotic activity against the U87 GBM cell line.
- These findings suggest Opuntiol's potential as an anti-cancer agent for GBM.
- Further mechanistic studies are warranted to explore Opuntiol's therapeutic development.
More Related Videos
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...


